UBS ASSET MANAGEMENT AMERICAS INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$306,722
-45.8%
71,000
-14.8%
0.00%
Q2 2023$565,6690.0%83,3090.0%0.00%
Q1 2023$565,669
+27.3%
83,309
+38.5%
0.00%
Q4 2022$444,509
-99.9%
60,1500.0%0.00%
Q3 2022$594,280,000
-9.4%
60,1500.0%0.00%
Q2 2022$655,635,000
-3.6%
60,1500.0%0.00%
Q1 2022$680,295,000
-27.9%
60,1500.0%0.00%
Q4 2021$943,755,000
-8.5%
60,1500.0%0.00%
Q3 2021$1,030,970,000
+0.2%
60,150
+25.7%
0.00%
Q2 2021$1,029,060,000
+66.1%
47,841
+16.0%
0.00%
Q1 2021$619,709,000
-1.4%
41,259
-13.8%
0.00%
Q4 2020$628,750,000
+36.0%
47,8500.0%0.00%
Q3 2020$462,232,000
-15.6%
47,8500.0%0.00%
Q2 2020$547,404,000
+17.3%
47,850
+6.2%
0.00%
Q1 2020$466,573,000
-28.5%
45,036
+13.3%
0.00%
Q4 2019$652,183,000
+10.0%
39,743
-11.0%
0.00%
Q3 2019$593,033,000
+22.6%
44,656
+30.1%
0.00%
Q2 2019$483,667,000
+44.8%
34,327
+89.1%
0.00%
Q1 2019$334,070,000
-4.8%
18,156
+35.3%
0.00%
Q4 2018$350,769,000
+129335.1%
13,424
-17.6%
0.00%
Q3 2016$271,000
+48.9%
16,3000.0%0.00%
Q2 2016$182,000
+48.0%
16,300
+10.9%
0.00%
Q1 2016$123,000
-56.5%
14,700
-51.6%
0.00%
Q4 2015$283,000
-20.9%
30,400
-4.4%
0.00%
Q3 2015$358,000
-5.5%
31,800
+6.4%
0.00%
Q2 2015$379,000
+43.0%
29,900
+4.9%
0.00%
Q1 2015$265,000
-32.7%
28,500
+3.6%
0.00%
Q4 2014$394,000
+217.7%
27,500
+131.1%
0.00%
Q3 2014$124,000
-35.8%
11,9000.0%0.00%
Q2 2014$193,00011,9000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders